Cargando…
Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells
Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the...
Autores principales: | Cheol Son, Ju, Woo Kang, Dong, Mo Yang, Kwang, Choi, Kang-Yell, Gen Son, Tae, Min, Do Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789262/ https://www.ncbi.nlm.nih.gov/pubmed/23989060 http://dx.doi.org/10.1038/emm.2013.75 |
Ejemplares similares
-
Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells
por: Hwang, Won Chan, et al.
Publicado: (2014) -
Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity
por: Park, Mi Hee, et al.
Publicado: (2015) -
The pleckstrin homology domain of phospholipase D1 accelerates EGFR endocytosis by increasing the expression of the Rab5 effector, rabaptin-5
por: Park, Mi Hee, et al.
Publicado: (2015) -
Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells
por: Kang, Dong Woo, et al.
Publicado: (2015) -
Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability
por: Park, Mi Hee, et al.
Publicado: (2014)